We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Veeva Systems Inc. (NYSE:VEEV) stands against the other health information services stocks.
Health Information Services stocks have become a key focus for investors as AI starts to enter more domains in 2025. Some of the most amazing gains have come in health information services stocks that are utilizing AI to improve research and services in the healthcare sector.
The healthcare information services sector allows investors to gain exposure to a number of growing and emerging technologies including cloud-backed software solutions to physician enablement platforms. Some of the companies in our list are surging based on earnings anticipation while others are increasing in share price because of their upcoming products or revenue growth.
To come up with our list of top 10 health information services stocks outpacing the broader market in 2025, we only considered stocks with a market cap of at least $2 billion that were outperforming the S&P 500 index.
A team of IT experts monitoring a network of computers managing the medical content and communications.
Veeva Systems Inc. (NYSE:VEEV)
Veeva Systems Inc. (NYSE:VEEV) is a cloud-based software provider for the life sciences industry. The company provides Veeva Vault Medical, Veeva Link, Veeva Commercial Cloud, Veeva Compass, Veeva OpenData, and Veeva Vault PromoMats. Goldman Sachs downgraded Veeva Systems Inc. (NYSE:VEEV) last month and decreased its target price from $261 to $200 due to medium-term risks. The share price declined 4% after the downgrade but the stock rebounded strongly with a 13% uptick this year.
Quarter over quarter, the company is showing a consistent recovery in its performance though there are some uncertainties associated with the industry that interrupted the upward momentum of the stock. Regardless of short-term instability, Veeva Systems Inc. (NYSE:VEEV) is well positioned for long-term growth due to its key area of expertise in life sciences, strong finances, and innovative approach.
This can further be supported by the strong earnings of Q3 and raised guidance for Q4 as the management is optimistic about the company’s prospects. In Q3, the company demonstrated solid revenue growth of 16.8% year-over-year. Net income went up by 37.5% and a 20.32% increase in free cashflows YoY. After strong Q3 earnings, the company has also raised its FY 2025 guidance.
Overall VEEV ranks 9th on our list of the health information services stocks outpacing the market in 2025. While we acknowledge the potential of VEEV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as VEEV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article was originally published at Insider Monkey.
